dc.contributor.authors |
Bilir, C; Durak, S; Kizilkaya, B; Hacibekiroglu, I; Nayir, E; Engin, H; |
|
dc.date.accessioned |
2020-02-27T08:26:12Z |
|
dc.date.available |
2020-02-27T08:26:12Z |
|
dc.date.issued |
2017 |
|
dc.identifier.citation |
Bilir, C; Durak, S; Kizilkaya, B; Hacibekiroglu, I; Nayir, E; Engin, H; (2017). Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status. CURRENT ONCOLOGY, 24, E204-E199 |
|
dc.identifier.issn |
1198-0052 |
|
dc.identifier.uri |
https://doi.org/10.3747/co.24.3486 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/65753 |
|
dc.description.abstract |
Conclusions Metronomic vinorelbine had an acceptable efficacy and safety profile in elderly patients with multiple comorbidities who had been diagnosed with advanced nsclc. Metronomic vinorelbine could be a treatment option for elderly patients with poor performance status who are unfit for platinum-based chemotherapy and intravenous single-agent chemotherapy, and who are not candidates for combination modalities. |
|
dc.language |
English |
|
dc.publisher |
MULTIMED INC |
|
dc.subject |
Oncology |
|
dc.title |
Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status |
|
dc.type |
Article |
|
dc.identifier.volume |
24 |
|
dc.identifier.startpage |
E199 |
|
dc.identifier.endpage |
E204 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Bilir, Cemil |
|
dc.contributor.saüauthor |
Hacıbekiroğlu, İlhan |
|
dc.relation.journal |
CURRENT ONCOLOGY |
|
dc.identifier.wos |
WOS:000404547500006 |
|
dc.identifier.doi |
10.3747/co.24.3486 |
|
dc.contributor.author |
Bilir, Cemil |
|
dc.contributor.author |
S. Durak |
|
dc.contributor.author |
B. Kizilkaya |
|
dc.contributor.author |
Hacıbekiroğlu, İlhan |
|
dc.contributor.author |
E. Nayir |
|
dc.contributor.author |
H. Engin |
|